Schneider et al. determined the expression levels of SPP1 and osteonectin (ON) in lung cancer tissues using quantitative reverse-transcription polymerase chain reaction and found that it was the increased expression of SPP1 rather than ON was associated with poor prognosis [21]. Here, SPARC is linked to lung cancer.